|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
�Դ������� |
|
ʵ���Ҽ����ͷ��� |
| ��������������� | |
|
ʯ�� |
|
������ |
| PubMed | |
|
Article by |
|
Article by |
�Դ���������ԭ���ⷽ�����о���״
ʯ��, ������
����ҽѧ��ѧԺ����ҽѧ�о���, ����100850
�Դ���������һ������Σ�����ཡ���ļ���,����һϵ�����صĹ����������˽������⡣���ŷ�������ѧ�ķ�չ,�Դ����������µ���Ϸ�������ӿ�֡������˶��½����ֵ�ø�������������顢���û�������Ӧ���ۺ�ø����Ӧ��ӫ��ۺ�ø����Ӧ������оƬ����Ϸ��������ص㡣
[2] Clad A, Freidank HM, Kunze M,et al. Detection of seroconversion and persistence of Chlamydia trachomatis antibodies in five different serological tests. Eur,J Clin Microbiol Infect Dis, 2000, 19:932-937.
[3] Morre SA, Munk C, Persson K, et al. Comparison of three commercially available peptide-based immunoglobulin G (IgG) and IgA assays to microimmunofluorescence assay for detection of Chlamydia trachomatis antibodies. J Clin Microbiol, 2002, 40:584-587.
[4] Verkooyen RP, Peeters MF, van Rijsoort-Vos JH, et al. Sensitivity and specificity of three new commercially available Chlamydia trachomatis tests. Int J STD AIDS, 2002,13:23-25.
[5] Ashley-Morrow R, Krantz E, Wald A. Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type I (HSV-1) or HSV-2. Sex Transm Dis, 2003, 30:310-314.
[6] Chan EL, Brandt K, Olienus K, et al. Performance characteristics of the Becton Dickinson ProbeTec System for direct detection of Chlamydia trachomatis and Neisseria gonorrhoeae in male and female urine specimens in comparison with the Roche Cobas System. Arch Pathol Lab Med, 2000, 124:1649-1652.
[7] Van Dyck E, Ieven M, Pattyn S, et al. Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by enzyme immunoassay, culture,and three nucleic acid amplification tests. J Clin Microbiol, 2001,39:1751-1756.
[8] Little MC, Andrews J, Moore R, et al. Strand displacement amplification and homogeneous real-time detection incorporated in a secondgeneration DNA probe system,.BDProbeTecET. Clin Chem, 1999,45:777-784.
[9] Leslie DE, Azzato F, Ryan N, et al. An assessment of the Roche Amplicor Chlamydia trachomatis/Neisseria gonorrhoeae multiplex PCR assay in routine diagnostic use on a variety of specimen types. Commun Dis Intell, 2003, 27:373-379.
[10] Abravaya K, Huff J, Marshall R, et al. Molecular beacons as diagnostic tools:technology and applications. Clin Chem Lab Med, 2003,41:468-474.
[11] Jordens JZ, Lanham S, Pickett MA, et al. Amplification with molecular beacon primers and reverse line blotting for the detection and typing of human papillomaviruses. J Virol Methods, 2000, 89:29-37.
[12] Whiley DM, LeCornec GM, Mackay IM, et al. A real-time PCR assay for the detection of Neisseria gonorrhoeae by LightCycler. Diagn Microbiol Infect Dis, 2002, 42:85-89.
[13] van Doornum GJ, Guldemeester J, Osterhaus AD, et al. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol, 2003, 41:576-580.
[14] Szuhai K, Sandhaus E, Kolkman-Uljee SM, et al. A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction. Am J Pathol, 2001,159:1651-1660.
[15] Crovella S, Pirulli D, De Santo D,et al. Quantitative in situ detection of high-risk human papillomavirus in cytological specimens by SYBR Green I fluorescent labeling. Clin Exp Med, 2002, 2:1-6.
[16] Fiandaca MJ, Hyldig-Nielsen JJ, Gildea BD, et al. Self-reporting PNA/DNA primers for PCR analysis. Genome Res, 2001, 11:609-613.
[17] An HJ,Cho NH,Lee SY, et al. Correlation of cervical carcinoma and precancerous lesions with human papillomavirus (HPV) genotypes detected with the HPV DNA chip microarray method. Cancer,2003,97:1672-1680.
[18] Kim CJ, Jeong JK, Park M, et al. HPV oligonucleotide microarraybased detection of HPV genotypes in cervical neoplastic lesions. Gynecol Oncol, 2003, 89:210-217.
[19] Mezzasoma L, Bacarese-Hamilton T, Di Cristina M, et al. Antigen microarrays for serodiagnosis of infectious diseases. Clin Chem, 2002,48:121-130.